Go Pro

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
3.3 of 5 stars
$22.85-1.8%N/AN/AModerate Buy$35.85
Ultragenyx Pharmaceutical (RARE)
3.5511 of 5 stars
$26.532.8%N/AN/AModerate Buy$59.44
Sarepta Therapeutics (SRPT)
2.363 of 5 stars
$23.218.8%N/AN/AHold$25.06
Pfizer (PFE)
3.8937 of 5 stars
$29.021.7%5.93%38.19Hold$28.28
Exelixis (EXEL)
2.8627 of 5 stars
$58.532.9%N/A18.41Hold$50.07
Moderna (MRNA)
1.501 of 5 stars
$150.81-2.2%N/AN/AHold$80.53
United Therapeutics (UTHR)
4.7376 of 5 stars
$492.02-4.0%N/A17.60Moderate Buy$646.00
Biogen (BIIB)
3.0871 of 5 stars
$222.673.1%N/A39.41Moderate Buy$227.79
Sanofi (SNY)
3.3926 of 5 stars
$44.470.2%3.96%23.28Hold$49.50
Eli Lilly and Company (LLY)
4.9216 of 5 stars
$1,160.520.0%0.60%38.94Moderate Buy$1,292.18
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines